ABBOTT LABORATORIES — Director's Dealing 2014

Feb 25, 2014

Page 1 of 1

SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

OMB APPROVAL

Washington, D.C. 20549

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB Number: 3235-0287 December 31, Expires: 2014

Estimated average burden hours per 0.5 response:

1. Name and Address of Reporting Person[] 2. Issuer Name and* Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to Issuer Funck Robert E ABBOTT LABORATORIES [ ABT ] (Check all applicable) Director 10% Owner Officer (give title Other (specify (Last) (First) (Middle) 3. Date of Earliest Transaction (Month/Day/Year) X below) below) 02/21/2014 100 ABBOTT PARK ROAD Vice President, Controller 4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable (Street) Line) ABBOTT X Form filed by One Reporting Person IL 60064 PARK Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (Instr. 3)	2. Transaction Date	2A. Deemed Execution Date,	3. Transaction	3. Transaction	4. Securities Disposed Of	Acquired (D) (Instr.	(A) or 3, 4 and	5. Amount of Securities	6. Ownership Form: Direct	7. Nature of Indirect
	(Month/Day/Year)	if any	Code	(Instr.	5)			Beneficially	(D) or Indirect	Beneficial
		(Month/Day/Year)	8)					Owned Following	(I) (Instr. 4)	Ownership
								Reported		(Instr. 4)
			Code	V	Amount	(A) or (D)	Price	Transaction(s) (Instr. 3 and 4)
Common shares without par value	02/21/2014		A		7,240 (1)	A	$0	67,468	D
										Profit
Common shares without par value								15,562 (2)	I	Sharing
										Trust
Common shares without par value								500 (3)	I	By daughter
Common shares without par value								500 (3)	I	By daughter

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of	2.	3. Transaction	3A. Deemed	4.		5. Number of	5. Number of	6. Date Exercisable and	6. Date Exercisable and	7. Title and Amount of	7. Title and Amount of	8. Price of	9. Number	10.	11. Nature
Derivative Security	Conversion	Date	Execution Date,	Transaction		Derivative		Expiration Date		Securities Underlying		Derivative	of	Ownership	of Indirect
(Instr. 3)	or Exercise	(Month/Day/Year)	if any	Code	(Instr.	Securities		(Month/Day/Year)		Derivative Security		Security	derivative	Form:	Beneficial
	Price of		(Month/Day/Year)	8)		Acquired (A)				(Instr. 3 and 4)		(Instr. 5)	Securities	Direct (D)	Ownership
	Derivative					or Disposed							Beneficially	or Indirect	(Instr. 4)
	Security					of (D) (Instr.							Owned	(I) (Instr. 4)
						3, 4 and 5)							Following
													Reported
											Amount		Transaction
											or		(s) (Instr. 4)
											Number
								Date	Expiration		of
				Code	V	(A)	(D)	Exercisable	Date	Title	Shares
Option (right to buy) (4)	$39.12	02/21/2014		A		44,325		02/21/2015	02/20/2024	Common shares	44,325	$0	44,325	D

Explanation of Responses:

1. These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

2. Balance in the Abbott Laboratories Stock Retirement Trust as of February 21, 2014.

3. The reporting person disclaims beneficial ownership of all securities held by his daughter.

4. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 14,775 on 2/21/2015, 14,775 on 2/21/2016, and 14,775 on 2/21/2017.

John A. Berry, Attorney-in02/25/2014 Fact for Robert E. Funck

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

2/25/2014